10x Genomics, Inc. (TXG) Contingent liabilities — Quarterly & Annual

Screener

Contingent liabilities at other companies

Unusual MachinesUMAC

$3M—

Energy FuelsUUUU

$1.77M+2.6%

Blink Charging Co.BLNK

$713K—

10x Genomics, Inc.TXG

$7.07M—

iRhythm Holdings, Inc.IRTC

$21M+100%

Rigel PharmaceuticalsRIGL

$5M—

Other financials

Income statement

Revenue$151.0M-12.6%

Gross profit$112.5M-10.1%

Operating income-$19.6M-165%

Net income-$17.9M-152%

EPS (diluted)-$0.14-150%

Balance sheet

Cash & equivalents$502.5M+26.4%

Total debt$78.8M-9.2%

Total equity$825.5M+6.8%

Total assets$1.0B+5.1%

Cash flow

Operating cash flow$17.0M-4.1%

CapEx$1.6M+0.6%

Free cash flow$15.4M-4.6%

Valuation

Market cap$6.61B+331%

Enterprise value$6.18B+406%

P/S10.7×+8.3×

Profitability

Gross margin70%+0.5pp

Operating margin-14.3%-1.1pp

Net margin-12.2%-0.8pp

FCF margin19.7%+10.9pp

Returns & leverage

Return on equity-9.4%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.7×-0.1×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent.

The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →

Filed: Aug 6, 2026, 8:00 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001628280-26-054491

FAQ

What is 10x Genomics, Inc.'s contingent liabilities?: 10x Genomics, Inc. (TXG) reported contingent liabilities of $7.07M in Q2 2026.
What does contingent liabilities mean?: Contingent liabilities as reported by 10x Genomics, Inc. Class A Common Stock.

Ask your AI about 10x Genomics, Inc.'s contingent liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk